The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation (2018)
- Authors:
- Ouellet, Véronique
- Aprikian, Armen
- Bergeron, Alain
- Brimo, Fadi
- Bristow, Robert G.
- Chevalier, Simone
- Drachenberg, Darrel
- Fazli, Ladan
- Fleshner, Neil E.
- Gleave, Martin
- Karakiewicz, Pierre
- Klotz, Laurence
- Lacombe, Louis
- Lattouf, Jean-Baptiste
- Kwast, Theodorus van der
- Squire, Jeremy Andrew
- Latour, Mathieu
- Trudel, Dominique
- Mes-Masson, Anne-Marie
- Saad, Fred
- Autor USP: SQUIRE, JEREMY ANDREW - FMRP
- Unidade: FMRP
- DOI: 10.1186/s12894-018-0392-x
- Subjects: NEOPLASIAS PROSTÁTICAS; BIOMARCADORES; IMUNOHISTOQUÍMICA; PROGNÓSTICO
- Keywords: Prostate cancer; Tissue microarray; Biomarker validation; Immunohistochemistry; Patient prognosis
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: BMC Urology
- ISSN: 1471-2490
- Volume/Número/Paginação/Ano: v. 18, art. 78, 2018
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
OUELLET, Véronique et al. The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation. BMC Urology, v. 18, 2018Tradução . . Disponível em: https://doi.org/10.1186/s12894-018-0392-x. Acesso em: 01 abr. 2026. -
APA
Ouellet, V., Aprikian, A., Bergeron, A., Brimo, F., Bristow, R. G., Chevalier, S., et al. (2018). The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation. BMC Urology, 18. doi:10.1186/s12894-018-0392-x -
NLM
Ouellet V, Aprikian A, Bergeron A, Brimo F, Bristow RG, Chevalier S, Drachenberg D, Fazli L, Fleshner NE, Gleave M, Karakiewicz P, Klotz L, Lacombe L, Lattouf J-B, Kwast T van der, Squire JA, Latour M, Trudel D, Mes-Masson A-M, Saad F. The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation [Internet]. BMC Urology. 2018 ; 18[citado 2026 abr. 01 ] Available from: https://doi.org/10.1186/s12894-018-0392-x -
Vancouver
Ouellet V, Aprikian A, Bergeron A, Brimo F, Bristow RG, Chevalier S, Drachenberg D, Fazli L, Fleshner NE, Gleave M, Karakiewicz P, Klotz L, Lacombe L, Lattouf J-B, Kwast T van der, Squire JA, Latour M, Trudel D, Mes-Masson A-M, Saad F. The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation [Internet]. BMC Urology. 2018 ; 18[citado 2026 abr. 01 ] Available from: https://doi.org/10.1186/s12894-018-0392-x - A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer
- Extracellular vesicles: evolving factors in stem cell biology
- Quantitative assessment of PTEN loss (qPTEN) is strongly associated with biochemical recurrence and may improve treatment decisions after surgery
- In silico shows that PTEN loss and AR overexpression are associated with increased CD8+ T-cell and Treg density and earlier disease recurrence in prostate cancer
- In prostate cancer needle biopsies, detections of PTEN loss by fluorescence in sity hybridization (FISH) and by immunohistochemistry (IHC) are concordant and show consistent association with upgrading
- STAT1-associated intratumoural TH1 immunity predicts chemotherapy resistance in high-grade serous ovarian cancer
- PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy
- Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma
- Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data
- Application of fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) for detecting PTEN loss in diagnostic prostate cancer needle biopsies
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
002936107.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
